Suppr超能文献

验证慢性肾脏病流行病学合作组(CKD-EPI)方程在晚期慢性肾衰竭中的应用。

Validation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in advanced chronic renal failure.

机构信息

Nephrology Department, Hospital Ramón y Cajal, Carretera de Colmenar km 9, Madrid, Spain.

出版信息

Nefrologia. 2011;31(6):677-82. doi: 10.3265/Nefrologia.pre2011.Sep.11014.

Abstract

INTRODUCTION

The aim of this work was to study the accuracy of the CKD-EPI equation to estimate the glomerular filtrate in patients with advanced chronic renal failure.

OBJECTIVE

We compared the estimations of Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Cockcroft-Gault (CG) equations to a glomerular filtration rate measured as the arithmetic mean of the urea and creatinine clearances (ClUrCr).

MATERIAL AND METHODS

The study was made in 89 nondialyzed patients with chronic renal disease in stage 4 or 5. Serum creatinine values were recalibrated to standardized creatinine measurements. In each patient, the difference between each estimating equation and the measured glomerular filtration rate was calculated. The absolute difference expressed as a percentage of the measured glomerular filtration rate indicates the intermethod variability.

RESULTS

Overall, the glomerular filtration rate measured as the ClUrCr was 14.5 ± 5.5 ml/min/1.73 m(2); and the results of the estimating equations were: MDRD 14.3 ± 5.5 (p = NS); CKD-EPI 13.6 ± 5.4 (p <0.01) and CG 16.8 ± 6.5 ml/min/1.73 m(2) (p <0.001). The variability of the estimating equations was 16 ± 12.2%, 16.7 ± 12,1% and 22 ± 15.6% (p <0.05), for MDRD, CKD-EPI and CG. The percentage of estimates within 30% above or below the measured glomerular filtration rate was 85% for MDRD, 88% for CKD-EPI and 70% for CG. The CG variability, but not MDRD variability or CKD-EPI variability, was influenced by gender (19.3 ± 15.1% in males vs 27.3 ± 15.5% in females, p <0.05) and showed a negative correlation with the glomerular filtration rate (r = -0.23, p <0.05) and the age (r = -0.24, p <0.05) and positive correlation with the body mass index (r = 0.37, p <0.001). In patients with chronic renal disease in stage 5, the variability of the different estimating equations was similar.

CONCLUSIONS

We conclude that in our population with advanced chronic renal failure, the CKD-EPI equation is as accuracy as the MDRD equation. With standardized creatinine the CG equation has a lower accuracy and its utilization may be reconsiderated.

摘要

简介

本研究旨在探讨 CKD-EPI 方程在评估晚期慢性肾衰竭患者肾小球滤过率时的准确性。

目的

我们比较了改良肾脏病膳食研究(MDRD)、慢性肾脏病流行病学合作(CKD-EPI)和 Cockcroft-Gault(CG)方程对以尿素和肌酐清除率算术平均值(ClUrCr)测量的肾小球滤过率的估计值。

材料和方法

本研究纳入了 89 例非透析慢性肾脏病 4 或 5 期患者。血清肌酐值经标准化肌酐测量值重新校准。在每位患者中,计算每个估算方程与实测肾小球滤过率之间的差异。以实测肾小球滤过率的百分比表示的绝对差值表明了方法间的差异。

结果

总体而言,ClUrCr 测量的肾小球滤过率为 14.5 ± 5.5 ml/min/1.73 m²;估算方程的结果为:MDRD 为 14.3 ± 5.5(p = NS);CKD-EPI 为 13.6 ± 5.4(p <0.01)和 CG 为 16.8 ± 6.5 ml/min/1.73 m²(p <0.001)。估算方程的变异性为 16 ± 12.2%、16.7 ± 12.1%和 22 ± 15.6%(p <0.05),分别用于 MDRD、CKD-EPI 和 CG。估计值在实测肾小球滤过率上下 30%以内的比例为 85%用于 MDRD,88%用于 CKD-EPI 和 70%用于 CG。CG 的变异性(但不是 MDRD 或 CKD-EPI 的变异性)受性别影响(男性为 19.3 ± 15.1%,女性为 27.3 ± 15.5%,p <0.05),并与肾小球滤过率(r = -0.23,p <0.05)和年龄(r = -0.24,p <0.05)呈负相关,与体重指数(r = 0.37,p <0.001)呈正相关。在慢性肾脏病 5 期患者中,不同估算方程的变异性相似。

结论

我们的结论是,在我们晚期慢性肾衰竭患者的人群中,CKD-EPI 方程与 MDRD 方程一样准确。使用标准化肌酐后,CG 方程的准确性较低,其应用可能需要重新考虑。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验